Tweet
Obstet Gynecol
. 2021 Sep 30.
doi: 10.1097/AOG.0000000000004607. Online ahead of print.
Maternal and Perinatal Outcomes Associated With the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Delta (B.1.617.2) Variant
Angela R Seasely 1 , Christina T Blanchard, Nitin Arora, Ashley N Battarbee, Brian M Casey, Jodie Dionne-Odom, Rachel G Sinkey, Jeff M Szychowski, Alan T Tita, Akila Subramaniam, CWRH COVID-19 Working Group
Affiliations
- PMID: 34592747
- DOI: 10.1097/AOG.0000000000004607
No abstract available
Conflict of interest statement
Financial Disclosure Rachel G. Sinkey reports money was paid to her institution from GestVision and ProLab. Alan T. Tita reports money was paid to his institution from the NIH, CDC, and Pfizer for COVID-19 and RSV vaccine in pregnancy studies. Ashley N. Battarbee reports money was paid to her institution from the NIH and CDC for COVID-19 in pregnancy studies. Akila Subramaniam reports money was paid to her institution from the NIH. Jeff M. Szychowski reports money was paid to his institution from the NIH. Jodie Dionne-Odom currently receives grant funding from NIH/NICHD for an unrelated study on infection in pregnancy. Nitin Arora reports money was paid to his institution from the Congenital and Perinatal Infections Consortium, the UAB Sparkman Center for Global Health, and the Kaul Pediatric Research Institute Grant Program. The other authors did not report any potential conflicts of interest.